Bill to Curb Prescription Drug Abuse, Safeguard Patients Supported by NACDS

Published Online: Tuesday, February 25, 2014
PRESS RELEASE

February 25, 2014, Arlington, Va. – The National Association of Chain Drug Stores (NACDS) today offered its support for new legislation - the Ensuring Patient Access and Effective Drug Enforcement Act of 2013 (H.R. 4069) - which calls for a collaborative, coordinated approach to curbing prescription drug abuse and safeguarding patients.

U.S. House of Representatives Energy and Commerce Committee Vice Chair Marsha Blackburn (R-TN) and Rep. Tom Marino (R-PA) introduced the legislation. The bill would establish a workgroup to explore opportunities to reduce prescription drug abuse and without comprising access to medications for patients who legitimately need them.

“NACDS and chain pharmacy are committed to partnering with federal and state agencies, law enforcement personnel, policymakers, and other stakeholders to work on viable strategies to simultaneously advance patient health and prevent prescription drug abuse,” said NACDS President and CEO Steven C. Anderson, IOM, CAE. “This legislation is an important step in addressing one of the most complex public health problems of our day.”

The workgroup would include equitable representation of healthcare and law enforcement entities up to 20 individuals. It would include representatives of the Food and Drug Administration, the Drug Enforcement Administration and the White House Office of National Drug Control Policy, as well as organizations representing patients, pharmacy, prescribers, hospitals, wholesalers, state attorneys general, law enforcement officials, and others with expertise in this area.

“It makes perfect sense that problems like drug abuse and meeting patients’ needs merit the highest form of collaboration among experts in government and in the private sector, but the best of intentions do not always provide that. We commend Reps. Marino and Blackburn for moving forward with this important concept,” Anderson said.

In its continued efforts to curb prescription drug abuse and diversion and ensure patient access to medications, NACDS has previously supported legislation introduced by U.S. Sen. Barbara Boxer to collaboratively address the problem through collaboration with law enforcement and healthcare stakeholders.
Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues
$auto_registration$